- Home
- RVPH vs BRIA Comparison
RVPH vs BRIA Comparison
Compare RVPH & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- BRIA
- Stock Information
- Founded
- RVPH 2006
- BRIA 2011
- Country
- RVPH United States
- BRIA Singapore
- Employees
- RVPH N/A
- BRIA N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- BRIA
- Sector
- RVPH Health Care
- BRIA
- Exchange
- RVPH Nasdaq
- BRIA NYSE
- Market Cap
- RVPH 87.6M
- BRIA 99.8M
- IPO Year
- RVPH N/A
- BRIA 2024
- Fundamental
- Price
- RVPH $1.92
- BRIA $3.56
- Analyst Decision
- RVPH Strong Buy
- BRIA
- Analyst Count
- RVPH 5
- BRIA 0
- Target Price
- RVPH $11.40
- BRIA N/A
- AVG Volume (30 Days)
- RVPH 3.0M
- BRIA 33.4K
- Earning Date
- RVPH 11-14-2024
- BRIA 02-15-2025
- Dividend Yield
- RVPH N/A
- BRIA N/A
- EPS Growth
- RVPH N/A
- BRIA N/A
- EPS
- RVPH N/A
- BRIA 92.24
- Revenue
- RVPH N/A
- BRIA $55,755,669.00
- Revenue This Year
- RVPH N/A
- BRIA N/A
- Revenue Next Year
- RVPH N/A
- BRIA N/A
- P/E Ratio
- RVPH N/A
- BRIA $0.04
- Revenue Growth
- RVPH N/A
- BRIA 8.03
- 52 Week Low
- RVPH $0.60
- BRIA $3.21
- 52 Week High
- RVPH $4.83
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- RVPH 52.37
- BRIA N/A
- Support Level
- RVPH $1.56
- BRIA N/A
- Resistance Level
- RVPH $2.06
- BRIA N/A
- Average True Range (ATR)
- RVPH 0.23
- BRIA 0.00
- MACD
- RVPH -0.01
- BRIA 0.00
- Stochastic Oscillator
- RVPH 52.46
- BRIA 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.